|
Video: What is a Stock Split?
|
|
Antares Pharma is a pharmaceutical company focused primarily on the development and commercialization of pharmaceutical products and technologies that address patient needs in targeted therapeutic areas. Co. develops, manufactures and commercializes, for itself or with partners, therapeutic products using its drug delivery systems. Co.'s U.S. Food and Drug Administration (FDA)-approved products include XYOSTED® (testosterone enanthate) injection; NOCDURNA® (desmopressin acetate); and Sumatriptan Injection USP. Co. is also the supplier of devices to Teva Pharmaceutical Industries, Ltd. for their Epinephrine Injection USP. According to our ATRS split history records, ATRS has had 0 splits. | |
|
ATRS (ATRS) has 0 splits in our ATRS split history database.
Looking at the ATRS split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ATRS shares, starting with a $10,000 purchase of ATRS, presented on a split-history-adjusted basis factoring in the complete ATRS split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
05/24/2022 |
|
Start price/share: |
$2.91 |
|
End price/share: |
$5.59 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
92.10% |
|
Average Annual Total Return: |
8.42% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$19,207.57 |
|
Years: |
8.07 |
|
|
|
|
|